Global Controlled Release Alliance Presents METHOCEL DC2 at CPhI 2014
Global Controlled Release Alliance, a partnership between Dow Pharma & Food Solutions and Colorcon, will present METHOCEL DC2 compressible hydroxypropyl methylcellulose at CPhI Worldwide 2014.
Dow Pharma & Food Solutions collaborated with Colorcon to form Global Controlled Release Alliance to increase pharmaceutical product development and global reach. At CPhI Worldwide 2014, Global Controlled Release Alliance will present METHOCEL DC2, a compressible hydroxypropyl methylcellulose designed to provide a more spherical particle morphology, eliminate wet-granulation steps, increase protection for sensitive APIs, reduce development time, and provide consistent performance for matrix formulation.
Dow Pharma & Food Solutions will be present at CPhI 2014 at booth 5H31. Colorcon will be present at booth 5H37.
Source: Dow
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
